Abstract
PCV15 and PCV20 received FDA approval in 2021. This article provides an overview of all pneumococcal vaccines - PPSV23, PCV13, PCV15, and PCV20 and their place in therapy. It provides a summary of pneumococcal disease burden in the U.S., vaccine spectrum of activity, indications, adult/pediatric dosing schedules, efficacy, and common adverse drug reactions.
Recommended Citation
Shin B, Do M, Lioudis E. Pneumococcal Vaccine Guidance 2022. Transformative Medicine. 2022; 1(4):83-87. doi: https://doi.org/10.54299/tmed/mrio3814.
Included in
Cardiovascular Diseases Commons, Immune System Diseases Commons, Interprofessional Education Commons, Other Pharmacy and Pharmaceutical Sciences Commons, Respiratory Tract Diseases Commons